 PENNINGTON, N.J. and SAN DIEGO, June 24, 2021 PRNewswire -- OncoSec Medical Incorporated NASDAQ:ONCS the Company or OncoSec today announced that Daniel OConnor has resigned and that Brian Leuthner, formerly Chief Operating Officer, has been appointed Interim Chief Executive Officer, effective June 25, 2021. 